Search - tctmd.com

Displaying 361 - 380 of 432

Sort: Relevancy | Date

Presentation TCT 2014

PFO/ASD Closure with a New Bioreabsorbable Device: Important Advance?

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, Sameer Gafoor

September 13, 2014

Presentation TCT 2014

PFO and Sleep Apnea

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, Michael J. Mullen

September 13, 2014

Presentation TCT 2014

Orthodeoxia-Platypnea

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, John C. Messenger

September 13, 2014

Presentation TCT 2014

Overview of PFO Closure for Migraines and Premium Trial Update

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel

September 13, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, John D. Carroll

September 13, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation TCT 2014

Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Abel Romero-Corral

September 13, 2014

Presentation

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Presenter: S. Elmariah

August 20, 2014

Presentation

Percutaneous Closure of Patent Foramen Ovale (PFO) in Patients with Cryptogenic Embolism

Presenter: S. Stortecky

August 14, 2014

Presentation Fellows 2014

PFO Closure: Indications and Technique

Presenter: Matthew Price

April 14, 2014

Presentation ECHO 2014

Imaging for Transcatheter Closure of ASD and VSD

Presenter: Robert J. Sommer

April 10, 2014

Presentation

Effect of Catheter-based PFO Closure on the Occurrence of Arterial Bubbles In Scuba Divers

Presenter: J. Hon?k

March 20, 2014

Presentation TCT 2013

For PFO Closure in Patients with a Long Tunnel

Presenter: John Lasala

October 30, 2013

Presentation TCT 2013

Exploring the Structural Landscape: Reflections on Three Important Closure Therapies (PFO, Mitral Edge-to-Edge, and LAA)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Effect of Intra-cardiac Echocardiography (ICE) and Yearly Operator Volume on Length of Stay and Cost of Care for Percutaneous Closure of Atrial Septal Defects and PFO: A Perspective of Last Decade

Presenter: Nileshkumar J. Patel

October 29, 2013

Presentation TCT 2013

ASD in the Elderly: Technical Approach and Results of Closure

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

What Is in the Pipeline for PFO Closure? Devices and Data

Presenter: Horst Sievert

October 27, 2013

Presentation TCT 2013

What Is in the Pipeline for ASD Closure? Devices and Data

Presenter: Zahid Amin

October 27, 2013

Presentation TCT 2013

PFO Closure: Regulatory Reform, FDA Approval, and Rational Dispersion in the United States

Presenter: John Carroll

October 27, 2013

Advertisement

PFO/ASD Closure with a New Bioreabsorbable Device: Important Advance?

PFO and Sleep Apnea

Orthodeoxia-Platypnea

Overview of PFO Closure for Migraines and Premium Trial Update

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence?

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Percutaneous Closure of Patent Foramen Ovale (PFO) in Patients with Cryptogenic Embolism

PFO Closure: Indications and Technique

Imaging for Transcatheter Closure of ASD and VSD

Effect of Catheter-based PFO Closure on the Occurrence of Arterial Bubbles In Scuba Divers

For PFO Closure in Patients with a Long Tunnel

Exploring the Structural Landscape: Reflections on Three Important Closure Therapies (PFO, Mitral Edge-to-Edge, and LAA)

Effect of Intra-cardiac Echocardiography (ICE) and Yearly Operator Volume on Length of Stay and Cost of Care for Percutaneous Closure of Atrial Septal Defects and PFO: A Perspective of Last Decade

ASD in the Elderly: Technical Approach and Results of Closure

What Is in the Pipeline for PFO Closure? Devices and Data

What Is in the Pipeline for ASD Closure? Devices and Data

PFO Closure: Regulatory Reform, FDA Approval, and Rational Dispersion in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content